Consistent with that, high levels of EIF4A3 were associated with lower survival in Retrospective‐1 and TCGA cohorts (Figure 2D), as well as with higher recurrence in HCC patients of Retrospective‐1 cohort (Figure 2E). This evidence concerns the gene EIF4A3 and hepatocellular carcinoma.